United States was Sotera Health’s largest region in fiscal 2025, bringing in $629.54M of $1.16B (54%).
| Geography | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| United States | $579.02M | $590.97M | $616.68M | $629.54M | |||
| Canada | $188.74M | $192.05M | $208.89M | $221.95M | |||
| Europe | $166.03M | $187.54M | $196.01M | $232.18M | |||
| Other | $69.90M | $78.73M | $78.86M | $79.95M | |||
| Total | $1.00B | $1.05B | $1.10B | $1.16B |
Sotera Health brought in $1.16B from its four regions in fiscal 2025, the year ended December 31, 2025. That was up 5.7% from $1.10B in fiscal 2024. United States was the largest at $629.54M (54.1%), ahead of Europe at $232.18M (20.0%) and Canada at $221.95M (19.1%). The remaining region, Other, brought in $79.95M.
Compared with fiscal 2024, Europe grew fastest, up 18.5% to $232.18M. Every region above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these regions grew from $1.00B to $1.16B, a compound annual growth rate of 5.1%. United States' share of the total fell from 57.7% to 54.1%.
Sterigenics was Sotera Health’s largest segment in fiscal 2025, bringing in $755.78M of $1.16B (65%).
| Segment | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Sterigenics | $626.65M | $667.13M | $697.85M | $755.78M | |||
| Nelson Labs | $223.40M | $221.70M | $229.23M | $220.22M | |||
| Nelson Labs | — | — | — | — | |||
| Nordion | $147.50M | $153.75M | $171.29M | $182.82M | |||
| Total | $997.55M | $1.04B | $1.10B | $1.16B |
Sotera Health brought in $1.16B from its three segments in fiscal 2025, the year ended December 31, 2025. That was up 5.5% from $1.10B in fiscal 2024. Sterigenics was the largest at $755.78M (65.2%), ahead of Nelson Labs at $220.22M (19.0%) and Nordion at $182.82M (15.8%).
Compared with fiscal 2024, Sterigenics grew fastest, up 8.3% to $755.78M, while Nelson Labs fell the most, down 3.9% to $220.22M. From fiscal 2022 to 2025, combined revenue from these segments grew from $997.55M to $1.16B, a compound annual growth rate of 5.1%. Sterigenics' share of the total rose from 62.8% to 65.2%.
Point In Time was Sotera Health’s largest revenue line in fiscal 2025, bringing in $755.78M of $976.00M (77%).
| Timing of Transfer of Good or Service | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Point In Time | $626.65M | $667.13M | $697.85M | $755.78M | |||
| Over Time | $223.40M | $221.70M | $229.23M | $220.22M | |||
| Total | $850.05M | $888.83M | $927.09M | $976.00M |
Sotera Health brought in $976.00M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That is less than the $1.16B it reports by geography, so these revenue lines do not cover all of its revenue. Point In Time was the largest at $755.78M (77.4%), ahead of Over Time at $220.22M (22.6%).
Compared with fiscal 2024, Point In Time grew 8.3% to $755.78M, while Over Time fell 3.9% to $220.22M.
Sotera Health (SHC) reports its revenue by geography, by segment and by timing of transfer of good or service. In fiscal 2025, United States was its largest region, bringing in $629.54M (54.1% of the total), followed by Europe at $232.18M (20.0%).
United States was Sotera Health's largest region in fiscal 2025, bringing in $629.54M, or 54.1% of the $1.16B total across its four regions.
Sterigenics was Sotera Health's largest segment in fiscal 2025, bringing in $755.78M, or 65.2% of the $1.16B total across its three segments.
Point In Time was Sotera Health's largest revenue line in fiscal 2025, bringing in $755.78M, or 77.4% of the $976.00M total across its two revenue lines.
Among Sotera Health's regions that make up at least 2% of revenue, Europe grew fastest in fiscal 2025, up 18.5% from $196.01M to $232.18M.
Every figure comes from Sotera Health's annual financial filings, as reported. Each line keeps the name Sotera Health gives it, and years follow its fiscal calendar.
Sotera Health's revenue by geography goes back to fiscal 2019, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.